Good morning :)
Place Order
Add to Watchlist

Brawn Biotech Ltd

BRAWN Share Price

18.140.00% (+0.00)

BRAWN Share Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹5 cr, stock is ranked 4,743
High RiskStock is 3.86x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹5 cr, stock is ranked 4,743
High RiskStock is 3.86x as volatile as Nifty

BRAWN Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
-3.301.08—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
49.816.380.53%

BRAWN Analyst Ratings & Forecast

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

BRAWN Company Profile

Brawn Biotech Limited is an integrated healthcare company in India, offering a wide range of pharmaceutical products including antibacterials, cardiovasculars, antifungals, and more.

BRAWN Similar Stocks (Peers)

Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
45.24
1Y Return
18.66%
Buy Reco %
88.24
Cipla Ltd
CIPLA
PE Ratio
30.21
1Y Return
9.48%
Buy Reco %
72.73
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
67.89
1Y Return
23.64%
Buy Reco %
68.00
Mankind Pharma Ltd
MANKIND
PE Ratio
55.15
1Y Return
7.57%
Buy Reco %
81.25
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
17.54
1Y Return
6.62%
Buy Reco %
46.67
Compare with Peers

BRAWN Forecasts

Price

Revenue

Earnings

BRAWN Share Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

BRAWN Company Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

BRAWN Stock EPS (Earnings Per Share) Forecast

Hmm, looks like data is unavailable here. Please come back after some time

BRAWN

Income

Balance Sheet

Cash Flow

BRAWN Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -24.12%, vs industry avg of 9.04%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.03% to 0%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue46.8961.1755.8765.9249.7935.298.6222.2416.5814.74
Raw Materialssubtract39.9952.0748.8258.4942.1529.8911.0519.2415.5916.27
Power & Fuel Costsubtract0.010.010.030.050.050.040.020.060.08
Employee Costsubtract1.861.982.983.023.082.361.801.401.40
Selling & Administrative Expensessubtract2.922.161.742.292.071.501.811.551.76
Operating & Other expensessubtract0.673.090.250.161.531.78-4.060.28-0.86
Depreciation/Amortizationsubtract0.030.030.030.030.030.030.050.110.100.12
Interest & Other Itemssubtract0.110.070.060.070.050.040.060.010.06—
Taxes & Other Itemssubtract0.360.360.680.480.230.20-0.470.45-0.30—
EPS3.134.674.274.432.00-1.83-5.47-2.87-4.17-5.50
DPS1.001.501.000.000.000.000.000.000.000.00
Payout ratio0.320.320.230.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

BRAWN Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

BRAWN Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Brawn Biotech Ltd-4.351.08—
Sun Pharmaceutical Industries Ltd45.246.460.75%
Cipla Ltd30.214.650.84%
Torrent Pharmaceuticals Ltd67.8916.400.84%

BRAWN Stock Price Comparison

Compare BRAWN with any stock or ETF
Compare BRAWN with any stock or ETF
BRAWN
Loading...

BRAWN Shareholdings

BRAWN Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

BRAWN Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

BRAWN Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding53.66%0.35%0.00%0.00%45.99%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

BRAWN Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

BRAWN Insider Trades & Bulk Stock Deals

Loading...

smallcases containing BRAWN stock

Looks like this stock is not in any smallcase yet.

BRAWN Events

BRAWN Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

BRAWN has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

BRAWN Upcoming Dividends

No upcoming dividends are available

BRAWN Past Dividends

Cash Dividend

Ex DateEx DateSep 12, 2018

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 12, 2018

Cash Dividend

Ex DateEx DateSep 14, 2017

Final
Final | Div/Share: ₹1.50

Dividend/Share

₹1.50

Ex DateEx Date

Sep 14, 2017

BRAWN Stock News & Opinions

Earnings
Brawn Biotech reports standalone net loss of Rs 0.43 crore in the December 2024 quarter

Net Loss of Brawn Biotech reported to Rs 0.43 crore in the quarter ended December 2024 as against net loss of Rs 0.61 crore during the previous quarter ended December 2023. Sales rose 35.21% to Rs 3.84 crore in the quarter ended December 2024 as against Rs 2.84 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales3.842.84 35 OPM %-10.42-20.42 - PBDT-0.40-0.58 31 PBT-0.43-0.61 30 NP-0.43-0.61 30 Powered by Capital Market - Live

2 months agoCapital Market - Live
Corporate
Brawn Biotech to table results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 12 February 2025.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Brawn Biotech reports standalone net loss of Rs 0.34 crore in the September 2024 quarter

Net Loss of Brawn Biotech reported to Rs 0.34 crore in the quarter ended September 2024 as against net loss of Rs 0.42 crore during the previous quarter ended September 2023. Sales rose 13.01% to Rs 3.30 crore in the quarter ended September 2024 as against Rs 2.92 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales3.302.92 13 OPM %-9.39-13.36 - PBDT-0.31-0.39 21 PBT-0.34-0.42 19 NP-0.34-0.42 19 Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Brawn Biotech to conduct board meeting

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

5 months agoCapital Market - Live
Corporate
Brawn Biotech to conduct AGM

Brawn Biotech announced that the 39th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live
Earnings
Brawn Biotech reports standalone net loss of Rs 0.53 crore in the June 2024 quarter

Net Loss of Brawn Biotech reported to Rs 0.53 crore in the quarter ended June 2024 as against net loss of Rs 0.17 crore during the previous quarter ended June 2023. Sales declined 44.31% to Rs 4.06 crore in the quarter ended June 2024 as against Rs 7.29 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales4.067.29 -44 OPM %-12.32-2.06 - PBDT-0.50-0.15 -233 PBT-0.53-0.17 -212 NP-0.53-0.17 -212 Powered by Capital Market - Live

8 months agoCapital Market - Live
Corporate
Brawn Biotech to discuss results

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 August 2024.Powered by Capital Market - Live

8 months agoCapital Market - Live

Frequently asked questions

  1. What is the share price of Brawn Biotech Ltd (BRAWN) today?

    The share price of BRAWN as on 30th April 2025 is ₹18.14. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Brawn Biotech Ltd (BRAWN) share?

    The past returns of Brawn Biotech Ltd (BRAWN) share are
    • Past 1 week: 6.71%
    • Past 1 month: 11.70%
    • Past 3 months: 11.91%
    • Past 6 months: -12.54%
    • Past 1 year: -23.30%
    • Past 3 years: -0.06%
    • Past 5 years: -41.48%

  3. What are the peers or stocks similar to Brawn Biotech Ltd (BRAWN)?

    The peers or stocks similar to Brawn Biotech Ltd (BRAWN) include:

  4. What is the market cap of Brawn Biotech Ltd (BRAWN) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Brawn Biotech Ltd (BRAWN) is ₹5.44 Cr as of 30th April 2025.

  5. What is the 52 week high and low of Brawn Biotech Ltd (BRAWN) share?

    The 52-week high of Brawn Biotech Ltd (BRAWN) is ₹27.82 and the 52-week low is ₹15.46.

  6. What is the PE and PB ratio of Brawn Biotech Ltd (BRAWN) stock?

    The P/E (price-to-earnings) ratio of Brawn Biotech Ltd (BRAWN) is -4.35. The P/B (price-to-book) ratio is 1.08.

  7. Which sector does Brawn Biotech Ltd (BRAWN) belong to?

    Brawn Biotech Ltd (BRAWN) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Brawn Biotech Ltd (BRAWN) shares?

    You can directly buy Brawn Biotech Ltd (BRAWN) shares on Tickertape. Simply sign up, connect your demat account and place your order.